Tampax Class Action Lawsuit: Who Qualifies and What Happens Next?

PFAS in Tampons: The Tampax Lawsuit

Tampax, Procter & Gamble's dominant tampon brand, controlling approximately 40% of the U.S. tampon market, faces a class action alleging that independent laboratory testing detected PFAS compounds and titanium dioxide in its products. These findings, if confirmed and legally established, represent a fundamental breach of the trust relationship between a women's health product brand and its customers: consumers purchasing Tampax relied on an implicit promise that an intimate-contact product sold by one of the world's largest consumer goods companies was safe for its intended use.

The science underlying menstrual product contamination concerns gained credibility from peer-reviewed research. A 2023 study in Environmental Science & Technology Letters analyzed 30 commercially available tampon products from 14 brands and detected measurable quantities of organic fluorine (an indicator of PFAS) in the majority of products tested. Consulting PFAS litigation attorneys can help evaluate your specific claim. This study triggered waves of litigation against multiple tampon manufacturers, with Tampax being among the highest-profile defendants given its market dominance and P&G's corporate resources.

The Legal Claims: What Plaintiffs Are Asserting

The Tampax class action pursues consumer protection claims under California's UCL and CLRA, New York's GBL, and parallel statutes in states with significant plaintiff populations. The theory: Tampax was marketed as a safe, reliable feminine hygiene product, its advertising emphasized purity and product integrity, and the discovery of PFAS contamination demonstrates that the product was not what was represented, entitling class members to return of the purchase price premium for contaminated products.

A products liability theory runs alongside the consumer protection claim. Tampax applicator and non-applicator tampons are classified as medical devices by the FDA, giving the agency regulatory authority over composition and safety standards. The FDA's November 2023 announcement of a study to evaluate chemical contaminants in tampons, and its subsequent June 2024 publication of testing data confirming lead, arsenic, and other metals in certain tampon products, provides substantial regulatory support for the litigation's factual claims, even though the FDA has not issued a specific recall of Tampax products.

Why Vaginal Absorption Makes This Different

The human vaginal mucosa is one of the most permeable tissues in the body, designed to absorb, which makes it an effective route for therapeutic drug delivery. This same permeability means chemical contaminants in contact with vaginal tissue have higher bioavailability than comparable exposures through food or skin contact. Toxicologists retained by plaintiff attorneys have argued that PFAS exposure from tampon use represents a more direct systemic exposure route than dietary PFAS intake, potentially making chronic tampon use a significant contributor to total lifetime PFAS body burden for affected individuals.

This biological argument distinguishes tampon product liability cases from general consumer product PFAS litigation and supports medical monitoring claims, seeking court-supervised health surveillance funds for regular Tampax users with elevated PFAS exposure concerns. Related: Cora tampons PFAS case and Rael menstrual pads litigation.

Who Qualifies for the Tampax Class Action?

Women who regularly used Tampax tampons during the class period (particularly long-term users who purchased Tampax for years or decades) are the core class members. Because tampons are a repeat-purchase product, documenting purchases is challenging but not impossible: subscription services, loyalty program records, and evidence of consistent purchasing patterns can support your claim. Class members with documented health conditions associated with PFAS exposure (thyroid dysfunction, fertility issues, certain cancers) may have elevated individual claim values beyond the class-level consumer protection recovery.

How to File a Claim: Step-by-Step

Once a settlement is approved, the process for filing a claim is typically as follows: (1) Visit the official settlement website designated by the court-appointed claims administrator. (2) Complete the online or paper claim form, providing your contact information, purchase history, and any required documentation. (3) Submit before the claims deadline, late claims are almost never accepted. (4) Wait for the claims administrator to review and verify your submission. (5) Receive your settlement check or electronic payment once the court grants final approval and any appeals are resolved.

Be wary of third-party services that charge fees to "help" you file a class action claim. Legitimate class action claim forms are always free to submit directly through the official settlement administrator's website.

How to File a Claim or Get Help

If you believe you qualify based on the eligibility criteria outlined above, the next step is a free consultation with an experienced attorney who handles this case type. Most plaintiff-side attorneys offer no-cost initial evaluations and work on contingency, meaning you pay nothing unless your case results in a recovery. Bring any relevant documentation to your consultation: receipts, medical records, correspondence, or any evidence of the harm you experienced.

To stay current on case developments, claim deadlines, and settlement news, bookmark this page and subscribe to the LawsuitWatch newsletter. We update our coverage as new court filings, settlement announcements, and eligibility changes are made public.